http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109172815-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate | 2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109172815-B |
| titleOfInvention | Application of the human urokinase-type peptidase in preparation treatment hypertension complicated with hyperlipemia drug |
| abstract | The invention belongs to field of medicaments, and in particular to the application of the novel medical use of human urokinase-type peptidase, i.e. human urokinase-type peptidase in preparation treatment hypertension complicated with hyperlipemia drug.In addition the present invention also provides the pharmaceutical composition containing human urokinase-type peptidase, which includes human urokinase-type peptidase and Breviscapinun, and main dosage form is injection liquor, is usually administered with Intravenous administration route.In the present invention, human urokinase-type peptidase composition has significant therapeutic effect to hypertension complicated with hyperlipemia. |
| priorityDate | 2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.